Gilead Sciences Unusual Options Activity For May 06
Gilead Sciences Unusual Options Activity For May 06
Financial giants have made a conspicuous bearish move on Gilead Sciences. Our analysis of options history for Gilead Sciences (NASDAQ:GILD) revealed 13 unusual trades.
金融巨頭對吉利德科學採取了明顯的看跌舉動。我們對吉利德科學（納斯達克股票代碼：GILD）期權歷史的分析顯示了13筆不尋常的交易。
Delving into the details, we found 38% of traders were bullish, while 61% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $274,737, and 7 were calls, valued at $398,087.
深入研究細節，我們發現38％的交易者看漲，而61％的交易者表現出看跌傾向。在我們發現的所有交易中，有6筆是看跌期權，價值爲274,737美元，7筆是看漲期權，價值398,087美元。
What's The Price Target?
目標價格是多少？
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $55.0 to $77.5 for Gilead Sciences over the last 3 months.
考慮到這些合約的交易量和未平倉合約，在過去的3個月中，鯨魚似乎一直將吉利德科學的價格定在55.0美元至77.5美元之間。
Volume & Open Interest Development
交易量和未平倉合約的發展
In today's trading context, the average open interest for options of Gilead Sciences stands at 860.38, with a total volume reaching 4,585.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Gilead Sciences, situated within the strike price corridor from $55.0 to $77.5, throughout the last 30 days.
在當今的交易背景下，吉利德科學期權的平均未平倉合約爲860.38，總交易量達到4,585.00。隨附的圖表描繪了過去30天內吉利德科學高價值交易的看漲和看跌期權交易量以及未平倉合約的變化，行使價走勢從55.0美元到77.5美元不等。
Gilead Sciences Option Volume And Open Interest Over Last 30 Days
吉利德科學過去 30 天的期權交易量和未平倉合約
Biggest Options Spotted:
發現的最大選擇：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GILD | CALL | SWEEP | BULLISH | 07/19/24 | $2.27 | $2.13 | $2.26 | $65.00 | $129.1K | 579 | 572 |
| GILD | CALL | TRADE | BEARISH | 06/21/24 | $5.55 | $5.45 | $5.47 | $60.00 | $109.4K | 172 | 200 |
| GILD | PUT | SWEEP | BEARISH | 06/20/25 | $2.8 | $2.42 | $2.8 | $55.00 | $74.4K | 768 | 173 |
| GILD | PUT | SWEEP | BEARISH | 08/16/24 | $4.85 | $4.75 | $4.85 | $67.50 | $51.8K | 1.4K | 108 |
| GILD | PUT | SWEEP | BEARISH | 08/16/24 | $2.17 | $2.16 | $2.17 | $62.50 | $41.6K | 2.0K | 232 |
| 符號 | 看跌/看漲 | 交易類型 | 情緒 | Exp。日期 | 問 | 出價 | 價格 | 行使價 | 總交易價格 | 未平倉合約 | 音量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 金 | 打電話 | 掃 | 看漲 | 07/19/24 | 2.27 美元 | 2.13 美元 | 2.26 美元 | 65.00 美元 | 129.1 萬美元 | 579 | 572 |
| 金 | 打電話 | 貿易 | 粗魯的 | 06/21/24 | 5.55 美元 | 5.45 美元 | 5.47 美元 | 60.00 美元 | 109.4 萬美元 | 172 | 200 |
| 金 | 放 | 掃 | 粗魯的 | 06/20/25 | 2.8 美元 | 2.42 美元 | 2.8 美元 | 55.00 美元 | 74.4 萬美元 | 768 | 173 |
| 金 | 放 | 掃 | 粗魯的 | 08/16/24 | 4.85 美元 | 4.75 美元 | 4.85 美元 | 67.50 美元 | 51.8 萬美元 | 1.4K | 108 |
| 金 | 放 | 掃 | 粗魯的 | 08/16/24 | 2.17 美元 | 2.16 美元 | 2.17 美元 | 62.50 美元 | 41.6K | 2.0K | 232 |
About Gilead Sciences
關於吉利德科學
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
吉利德科學開發和銷售治療危及生命的傳染病的療法，其產品組合的核心集中在艾滋病毒以及乙型和丙型肝炎上。對Corus Pharma、Myogen、CV Therapeutics、Arresto Biosciences和Calistoga的收購擴大了這一關注範圍，將肺部和心血管疾病以及癌症包括在內。吉利德對Pharmasset的收購帶來了丙型肝炎藥物Sovaldi的版權，該藥物也是複方藥物Harvoni的一部分，而對Kite、Forty Seven和Immunomedics的收購增加了吉利德在腫瘤學領域接受細胞療法和非細胞療法的機會。
Gilead Sciences's Current Market Status
吉利德科學的當前市場狀況
- Trading volume stands at 3,631,936, with GILD's price up by 0.63%, positioned at $65.19.
- RSI indicators show the stock to be may be oversold.
- Earnings announcement expected in 87 days.
- 交易量爲3,631,936美元，GILD的價格上漲了0.63％，爲65.19美元。
- RSI指標顯示該股可能被超賣。
- 預計將在87天內公佈業績。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
與僅交易股票相比，期權是一種風險更高的資產，但它們具有更高的獲利潛力。嚴肅的期權交易者通過每天自我教育、擴大交易規模、關注多個指標以及密切關注市場來管理這種風險。
譯文內容由第三人軟體翻譯。